Axcend Awarded a Phase II SBIR Grant from the National Institutes of Health
This Phase II SBIR Grant continues successful Phase I research by Axcend to develop a “Portable Liquid Chromatography Platform for Diverse Pharmaceutical Applications” March 4, 2021 — Axcend® today announced that it has been awarded a Phase II SBIR Grant to continue its work in developing a “Portable Liquid Chromatography Platform for Diverse Pharmaceutical Applications.” …
Axcend Awarded a Phase II SBIR Grant from the National Institutes of Health Read More »